Catalyst Pharmaceuticals
CPRX
#3793
Rank
S$3.40 B
Marketcap
$28.03
Share price
0.72%
Change (1 day)
30.35%
Change (1 year)

Operating Margin for Catalyst Pharmaceuticals (CPRX)

Operating Margin as of March 2025 (TTM): 43.97%

According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 43.97%. At the end of 2024 the company had an Operating Margin of 39.68%.

Operating Margin history for Catalyst Pharmaceuticals from 2019 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
202439.68%82.01%
202321.80%-54.14%
202247.54%27.81%
202137.20%7.23%
202034.69%11.51%
201931.11%-100.44%
2018-7,059.03%
2010-823.01%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
18.98%-56.83%๐Ÿ‡บ๐Ÿ‡ธ USA
13.71%-68.82%๐Ÿ‡บ๐Ÿ‡ธ USA
18.78%-57.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-84.50%-292.18%๐Ÿ‡บ๐Ÿ‡ธ USA
12.60%-71.34%๐Ÿ‡บ๐Ÿ‡ธ USA
16.71%-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.